InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 09/28/2012

Re: friendofthedevil post# 5183

Thursday, 03/02/2017 12:16:28 PM

Thursday, March 02, 2017 12:16:28 PM

Post# of 8547
"Roche Holding AG’s breast cancer medicine Perjeta succeeded in the drugmaker’s most hotly anticipated patient study, a key step for a franchise that could exceed $9 billion in sales by 2021. The stock soared."

https://www.bloomberg.com/news/articles/2017-03-02/roche-s-perjeta-succeeds-with-key-aphinity-breast-cancer-study
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News